Granulated mesalamine ( DrugBank: Mesalamine )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
97	Ulcerative colitis	2

97. Ulcerative colitis

---

Clinical trials : 2,630 /  Drugs : 1,459 - (DrugBank : 265) / Drug target genes : 144 - Drug target pathways : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00744016 (ClinicalTrials.gov)	December 2004	27/8/2008	Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative Colitis	A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Use of Mesalamine Pellet Formulation 1.5G QD to Maintain Remission From Mild to Moderate Ulcerative Colitis	Ulcerative Colitis	Drug: Granulated mesalamine;Drug: Placebo	Bausch Health Americas, Inc.	NULL	Completed	18 Years	N/A	All	305	Phase 3	United States
2	NCT00767728 (ClinicalTrials.gov)	December 2004	17/9/2008	Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative Colitis	A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Use of Mesalamine Pellet Formulation 1.5G QD to Maintain Remission From Mild to Moderate Ulcerative Colitis	Ulcerative Colitis	Drug: Granulated mesalamine;Drug: Placebo	Bausch Health Americas, Inc.	NULL	Completed	18 Years	N/A	All	256	Phase 3	United States